GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 1.800
0.00 (0.00%)
Aug 1, 2025, 4:35 PM GMT+1
GENinCode Revenue
In the year 2024, GENinCode had annual revenue of 2.70M GBP with 25.05% growth. GENinCode had revenue of 1.31M in the half year ending December 31, 2024, with 71.28% growth.
Revenue
2.70M
Revenue Growth
+25.05%
P/S Ratio
1.91
Revenue / Employee
64.31K
Employees
42
Market Cap
5.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.70M | 541.00K | 25.05% |
| Dec 31, 2023 | 2.16M | 730.00K | 51.05% |
| Dec 31, 2022 | 1.43M | 276.00K | 23.92% |
| Dec 31, 2021 | 1.15M | 193.00K | 20.08% |
| Dec 31, 2020 | 961.00K | -480.49K | -33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
GENinCode News
- 26 days ago - AIM Market Roundup: Coral Products, Bezant Resources, Jarvis Securities - The Armchair Trader
- 6 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 6 months ago - AIM Market Roundup: GENinCode, Empyrean, Watkins Jones - The Armchair Trader
- 11 months ago - Half Year 2024 Genincode PLC Earnings Presentation Transcript - GuruFocus
- 11 months ago - Half Year 2024 Genincode PLC Earnings Presentation (Shareholder Q&A) Transcript - GuruFocus